News & Updates
Filter by Specialty:
Extensive influenza testing needed in pneumonia patients
Most patients with community-acquired pneumonia go untested for influenza even during flu season, which is unfortunate since a positive test result facilitates antiviral therapy, and early treatment leads to lower mortality, according to a study.
Extensive influenza testing needed in pneumonia patients
10 Feb 2022
Casirivimab-imdevimab combo prevents progression from asymptomatic to symptomatic COVID-19
Treatment with the combination therapy of casirivimab and imdevimab prevents the risk of developing symptomatic COVID-19 among asymptomatic individuals with SARS-CoV-2 infection in a household close-contact setting, according to a recent study.
Casirivimab-imdevimab combo prevents progression from asymptomatic to symptomatic COVID-19
10 Feb 2022
CPAP reduces tracheal intubation, mortality in adults with COVID-19–related acute hypoxemic respiratory failure
The use of continuous positive airway pressure (CPAP) significantly reduces the risk of tracheal intubation and mortality among hospitalized patients with COVID-19–related acute hypoxemic respiratory failure, according to the RECOVERY-RS* trial.
CPAP reduces tracheal intubation, mortality in adults with COVID-19–related acute hypoxemic respiratory failure
08 Feb 2022
Fungal infections common in COVID-19 patients who require mechanical ventilation
Patients with COVID-19 who received mechanical ventilation while admitted to the intensive care unit (ICU) have an elevated risk of invasive fungal infections (IFIs), according to results of the MYCOVID study from France. Furthermore, patients with COVID-19–associated pulmonary aspergillosis (CAPA) may be at an increased risk for death.
Fungal infections common in COVID-19 patients who require mechanical ventilation
07 Feb 2022
Quercetin augments therapeutic benefit of antivirals for COVID-19
In patients hospitalized for severe COVID-19, adding the plant flavonoid quercetin to the antiviral drugs remdesivir or favipiravir reduced hospitalization period and levels of inflammatory markers related to the pathogenesis of SARS-CoV-2, thus preventing the progression of the disease into its critical phase, suggests an open-label study from Iran.
